After much controversy, more resignations in protest against the FDA accelerated approval of Biogen’s Alzheimer’s drug Aduhelm (aducanumab). In a bold act of protest…
Looking for answers about Alzheimer’s treatment Aduhelm (generic name aducanumab)? Here’s a primer on what it is, what it does, and more, according to…
Following the FDA’s approval of aducanumab, marketed under the name Aduhelm, an aducanumab trial principal investigator and a former aducanumab trial site investigator speak…
The FDA is expected to decide whether or not to approve Biogen and Eisai’s experimental Alzheimer’s drug, aducanumab, in less than a week. Geri…
Being Patient will speak with Ed Blonz, assistant clinical professor at UCSF’s Department of Clinical Pharmacy, about the potential link between Alzheimer’s and deficits…
Image: Phil Gutis receives an aducanumab infusion while carrying out his “silly shoe challenge.” Phil Gutis reflects on the significance of participating in the…
In case you missed them, our editors and contributors round up their most recommended reads from the month of May in Being Patient Reads…